Copycats bite AbbVies’ top-selling drug Humira
When Humira, AbbVies’ record-breaking immunology drug, went off patent early last year after generating more than $200 billion in sales for the maker over two decades, a slew of cheaper …
When Humira, AbbVies’ record-breaking immunology drug, went off patent early last year after generating more than $200 billion in sales for the maker over two decades, a slew of cheaper …
In the days leading up to a competition, bodybuilders deny themselves almost all human pleasures. Food, water, and sex are routinely restricted to levels that put immense strain on their …
The Ministry of Ayush has reportedly issued a warning to all ayurvedic, siddha, unani and homeopathic drug makers after the Supreme Court pulled up Patanjali Ayurved Ltd in connection with …